Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population

Objective: The aim of this study was to evaluate the association between the methylenetetrahydrofolate reductase (MTHFR) C677T excision repair cross-complementation group 1 (ERCC1) genetic polymorphisms and the clinical efficacy of gemcitabine-based chemotherapy in advanced non-small cell lung cance...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hong, Wei, Wang, Kai, Zhang, Yi-ping, Kou, Jun-yan, Hong, Dan, Su, Dan, Mao, Wei-min, Yu, Xin-min, Xie, Fa-jun, Wang, Xiao-jian
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Zhejiang University Press 2013
Gaiak:
Biomedicine
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3596571/
https://ncbi.nlm.nih.gov/pubmed/23463763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1631/jzus.B1200101
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak